AUSTRALIA’S LEADING DISTRIBUTOR OF MEDICINAL CANNABIS

Since being Australia’s first company to import medicinal cannabis in 2017, our unwavering commitment to quality and service has positioned HHI Australia as the leading market partner for the best of Australian and international medicinal cannabis producers. From our base in Western Australia, HHI operates a state-of-the-art, national distribution business dedicated to supporting our valued suppliers and customers in consistently meeting the demands and needs of patients.

MedTEC Pharma is a local South Australian company cultivating outdoor sun-grown medicinal cannabis at scale in living soil on a 12Ha site in the Riverlands. Focussing on a sustainable and environmentally-friendly approach to cannabis production, our high-tech netting, arid climate, and natural UV irradiation allow us to produce the highest quality of flower with complex terpenes and flavonoids, all while minimising pests and diseases.

We are medicinal cannabis with Provenance: trace the journey, embrace the source, trust the plant.


Heyday doctors carefully select the highest quality strains to develop medicines that are patient centred, efficacious and unique. The Heyday range of full spectrum cannabis oil and flower medicines are as good for Aussie patients as they are for the planet. Heyday flowers is sun grown in rural Victoria, some in polytunnels, some outdoors – using up to 96x less energy than indoor grows. Heyday flower is grown in living soil, with only local, organic compost added and the grow facility uses regenerative farming practices. Heyday medicines are AU GMP, high quality and fresh.

Humacology crafts Australia’s most effective and affordable medicinal cannabis, replete with our proprietary blend of terpenes to aid in their efficacy, Crafted by Australian doctors for Australian patients, Humacology believes in the power of nature to heal.

Little Green Pharma was the first medical cannabis company in Australia to produce locally grown medical-grade cannabis products. Their medicinal cannabis products include a range of oils and dry cannabis flower tested to stringent Australian quality standards. Little Green Pharma also works closely with medical practitioners to assist them with applications for medical cannabis products; saving patients time and money.

Ananda Hemp offers high-quality products made with full spectrum CBD oil extracted from 100% Kentucky-grown hemp. Every plant that goes into their high-end line of CBD products is cultivated using organic farming practices. They also contain an array of cannabinoids and hundreds of bioactive phytonutrients from the hemp – resulting in a formula that is truly deserving of the title ‘full spectrum’.

The Australian Maali range is sun grown, sustainably in living soil in Regional Victoria, with a range of flower formulations offering patients a variety of clinical effects. The cannabis flower is of highest quality, under Australian GMP and depending on the dry cannabis flower prescribed, will also contain a unique mix of terpenes to reinforce cannabinoid therapy for patients.

 

Botanitech is an Australian brand built on the desire to provide high-quality medication to the broad range of patients in the Australian market.

Botanitech exists for the benefit and wellbeing of patients.

We collaborate with healthcare professionals to make our high-quality medications accessible to patients across Australia.

Endoca Australia combines pharmaceutical expertise with high quality organic cannabis cultivation and extraction to offer an innovative range medical cannabis. With experience servicing patients all around Australia, we deliver pure and high-quality cannabis products at the best prices.

Zelira is a global biopharmaceutical company researching, developing, and marketing clinically validated cannabinoid-based medicines. Zelira are committed to world class science and the clinical validations of cannabinoid-based medicines. The company’s focus is on specific conditions, like chronic insomnia and autism spectrum disorder (ASD), and delivering solutions to patients who are no longer receiving a benefit from their conventional treatments.

Satipharm CBD Advanced capsules have been specifically developed to maximise bioavailability, resulting in significantly higher amounts of CBD absorbed. The capsules are available in two strengths with Gelpell technology to ensure cannabinoid stability and consistent dosing and absorption.

 

IX Biopharma has developed a range of sublingual wafers containing cannabidiol (CBD) and tetrahydrocannabinol (THC) by using its patented sublingual delivery technology, WaferiX™, Xativa™ CBD, Hypera™ THC each contain a nano-emulsion of highly bioavailable cannabis extract designed for rapid under-the-tongue absorption.

Australian Natural Therapeutics Group (ANTG) is Australia’s first GACP & GMP accredited medicinal flower cultivation and manufacturing facility. It is Australian grown and made, cultivated in NSW, with all natural, renewable medium, without harmful pesticides. ANTG’s aim is for all Australians to benefit from high-quality, affordable and locally produced medicines.

At Chemovar, we combine the power of science with the beauty of nature to create a holistic medicinal cannabis experience for our Australian Doctors and their Patients. Our unique classification system blends analytical and intuitive thinking to provide a selection of treatments categorised by their aroma.

Turkken is Australia’s number one Halal-certified GMP medical cannabis oil company. Australian owned and operated. Made using only Australian flower. Export ready.

Discover an elevated experience with our premium flower strains, meticulously cultivated and featuring exclusive day and night formulas grown in Australia. Experience the artistry of nature’s remedy, carefully crafted for a quantum leap in well-being. Embrace the future of cannabis with Quantum Medical Cannabis.


Sativite grow and distribute premium medicinal cannabis products – including selected varieties of high-quality, organically and sustainably grown dried flower and broad-spectrum extracts and oils with a range of cannabinoid profiles, as well as innovative cannabis-based medicines and delivery devices from leading licensed suppliers worldwise.

Medigrowth is an Australian medicinal cannabis biotech with multi-disciplinary research involvement spanning plant science & next-gen technologies in biomedical analysis. Medigrowth is driven by a deep passion to improve quality of life for Australian patients. Industry partnership and university-led Australian Research Council Initiatives ensures Medigrowth continues the commitment to development and discovery.

 

 

With the continuous pursuit of excellence and innovation, CCELL has become one of the world’s largest vaporizer suppliers since its establishment in 2016. CCELL is the most renowned world-class vaping device provider who revolutionized the industry by introducing the world’s first ceramic heating component and owns multiple independent research institutes and state-of-the-art production facilities.

 

All VAPORMED MEDIC vaporisers are medically certified and are included on the Australian Register of Therapeutic Goods. (ARTG entry 319028).

Using a patented heating technology, VAPORMED combine the use of convection and conduction heating to provide continuous vaporisation, producing vapour right from the first breath.

 

The Fenix dry herb vaporizers stand out prominently among the top choices within the mid-priced range of vaporization devices. Renowned for their exceptional quality and performance, Fenix devices have established themselves as pioneers in the realm of innovative convection heating techniques, setting a new standard for the effective and uniform vaporization of your chosen herbs.

Health House International Ltd is part of the Melodiol Global Health Group

Melodiol is a global business with activities spanning recreational and medical cannabis, CBD, psychedelics and plant based consumer goods.

Global Cannabis Landscape

Over 60 countries around the world have now legalised medical cannabis.

Timeline: Towards a Legal Medicinal Cannabis Market

DATE
Nov 1996

California

California passes Proposition 215. It becomes the first US state to legalise medicinal cannabis.

DATE
July 2001

Portugal

Portugal decriminalises the use of all drugs.

DATE
July 2001

Canada

Canada passes the Medicinal Marijuana Access Program, which allows clinicians to prescribe medicinal cannabis.

DATE
Nov 2004

Montana

Montana becomes tenth US state to legalise medicinal cannabis.

DATE
Aug 2011

Israel

Israel approves the first government sanctioned cannabis growing operations.

DATE
Nov 2012

Colorado & Washington

Colorado and Washington become the first two states to legalise the recreational use of cannabis.

DATE
May 2013

U.K

UK-based GW Pharmaceuticals, listed on the AIM London market, dual lists on the US NASDAQ.

DATE
April 2014

Canada

Canada introduces the Medical Purposes Regulations, which lets patients access the drug from licensed producers.

DATE
Mar 2015

Italy

The Italian parliament signs a motion to legalise cannabis.

DATE
June 2016

Canopy Growth

Canopy Growth becomes the first cannabis stock to list on the Toronto Stock Exchange.

DATE
Jan 2017

Germany

Germany passes a law legalising the use of cannabis for medical purposes.

DATE
Feb 2017

Israel

Israel announces it will exports of medicinal cannabis.

DATE
Mar 2017

U.K

Sativa becomes the UK’s first medical cannabis investment vehicle to be listed on the NEX Exchange.

DATE
July 2017

Poland

Poland votes in favour of legalising medicinal cannabis.

DATE
Jan 2018

Canada

Canada’s Aurora Cannabis and CanniMed Therapeutics $3.2 billion merger becomes the industry’s biggest M&A deal.

DATE
May 2018

Canada

Canada’s Cronos Group becomes the first cannabis company to list on the US NASDAQ.

DATE
Jul 2018

U.K

UK Home Secretary Sajid Javid changes the classification of medicinal cannabis to Schedule 2.

DATE
Nov 2018

U.K

Medicinal cannabis available on prescription in the UK.

News & Media